1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bumetanide in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (bumetanide) | Trials (bumetanide) | Recent Studies (post-2010) (bumetanide) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 2,033 | 150 | 354 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | bumetanide (IC50) |
---|---|---|---|
Solute carrier family 12 member 2 | Homo sapiens (human) | 0.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garay, RP; Senn, N | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bumetanide
Article | Year |
---|---|
Regulation of Na+ and K+ contents in rat thymocytes.
Topics: Animals; Biological Transport; Blood Coagulation Factors; Bumetanide; Dinoprostone; Hypertension; Isoproterenol; Kinetics; Male; Ouabain; Platelet Activating Factor; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Sodium; Sodium Channels; T-Lymphocytes | 1989 |